Perspective: Next-Generation Proteomics Holds the Key to Success for Immuno-Oncology Drug Development
Genomeweb,
Several studies presented at the 2023 American Association for Cancer Research (AACR) meeting by mass spectrometry (MS…
Several studies presented at the 2023 American Association for Cancer Research (AACR) meeting by mass spectrometry (MS…
Although tumor mutational burden is established as a clinically informative feature of tumors, its optimal use in therapeutic…